ORLANDO, Fla. - July 31, 2019 -CSI Specialty Group, a leading consulting and talent acquisition firm serving diverse stakeholders in specialty pharmacy, released its exclusive annual report on the industry. The 2019 State of Specialty Pharmacy Report: Tracking the Future of Specialty Pharmacy, is free to download and provides data and analysis obtained from a recent survey of key health care leaders.
Unique in the market, this report is in in its third year of publication and reflects noteworthy and actionable insights from four major stakeholder groups in the specialty pharmacy sector: Pharmaceutical manufacturers, Health Systems, Independent Specialty Pharmacies, and Payors. The report uncovers trends, opinions, and predictions for the future of the industry.
"We appreciate the time and candid reflections of all those who contributed to this year's survey," said James Flanick, RPh, MBA, Chief Operating Officer, CSI Specialty Group. "Our goal is to leverage that collaboration of knowledge of high-level leaders into something that is, in aggregate, more valuable than the sum of its parts. Providing actionable information based on years of experience is fundamental to our mission, so we are happy to share this valuable tool in the hopes others can benefit from the insight it provides."
Some key takeaways include:
The forecast for growth in Specialty remains strong as 60% of drugs in FDA's approval pipeline through 2021 are Specialty Drugs.
During the next 10-15 years, therapies will center on more targeted drugs designed for smaller patient populations.
Health systems continue to develop specialty pharmacy strategies, as the significance of this component of pharmacy has reached the senior executive level.
Accreditation remains relevant as an imperative pedigree for accessing limited distribution and payor networks.
Those interested in downloading the report can access it at https://www.csigroup.net/survey
About CSI Specialty Group
CSI Specialty Group is a globally recognized leadership consulting firm dedicated to providing solutions that continually elevate the specialty pharmacy industry and improve the patient journey. By providing inventive consulting, workforce planning and talent acquisition solutions, we uniquely tailor our service offerings to help clients drive sustainable, accelerated growth. CSI is at the forefront of pioneering innovative concepts to meet the changing needs of specialty pharmacy, home infusion, mail order/PBM, health systems and pharma/biotech clients across the USA as well as internationally.
For more information about CSI Specialty Group, visit www.CSIgroup.net.
Media Contact
Andrew Maddigan, VP, Client Engagement
